CRESCENT BIOPHARMA, INC. (CBIO) Options Statistics & Positioning
CRESCENT BIOPHARMA, INC. (CBIO) options trade at a 30-day at-the-money implied volatility of 413.7%, an IV rank of 0 out of 100 over the past year. The options market prices a ±$8.53 (±57.3%) move in CBIO for the front expiration. Max pain sits at $10 and the put/call open interest ratio is 0.01. Statistics are computed by OptiView from delayed OPRA options data and refresh every trading day.
Data as of Oct 9, 2026, 3:55 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.
Explore CBIO Options Statistics
Upcoming Earnings
CBIO's next expected earnings date is Nov 8, 2026. Options currently price a ±$8.53 (±57.3%) move for the front expiration.
Explore the payoff profile of option on CBIO for free
Build multi-leg CBIO strategies, visualize payoffs, and scan the full US options universe with OptiView.
CBIO Options FAQ
When is CBIO's next earnings date?
CBIO's next expected earnings date is Nov 8, 2026. Options currently price a ±$8.53 (±57.3%) move for the front expiration.
How often is CBIO options data on this page updated?
All CBIO statistics on this page are computed by OptiView from delayed OPRA options data and refresh every trading day after the session close.
Where can I see CBIO max pain, open interest, and implied volatility in detail?
OptiView publishes dedicated CBIO pages for implied volatility, max pain, open interest, gamma exposure, options volume, and the most active contracts — each with charts, history, and a plain-English explanation of what the numbers mean.
Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.
Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.